Imugene Market Cap

Imugene has a market cap or net worth of 95.53 million as of July 2, 2025. Its market cap has decreased by -77.88% in one year.

Market Cap

95.53M

Enterprise Value

77.55M

Revenue

-1.84M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.48

Market Cap Chart

Since September 17, 2002, Imugene's market cap has increased from 7.38M to 95.53M, an increase of 1,194.71%. That is a compound annual growth rate of 11.88%.

Market Cap History

Date	Market Cap	% Change
Jul 2, 2025	95.53M	-65.28%
Dec 31, 2024	275.18M	-65.11%
Dec 29, 2023	788.60M	-15.31%
Dec 30, 2022	931.15M	-59.62%
Dec 31, 2021	2.31B	386.45%
Dec 31, 2020	474.09M	234.74%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	115.36B
Pro Medicus	29.43B
Cochlear	19.92B
Sonic Healthcare	13.21B
Ramsay Health Care	8.84B
Telix Pharmaceuticals	8.37B
Ansell	4.46B
Mesoblast	2.35B

Market Cap Rankings